{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:37:29Z","timestamp":1791661049308,"version":"4.3.4"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01817","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T06:02:33Z","timestamp":1595311353000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":205,"title":["The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies"],"prefix":"10.3389","volume":"11","author":[{"given":"Lea Skak Filtenborg","family":"Frederiksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Foged","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China - key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","unstructured":"32494854Coronavirus Disease 2019 (COVID-19): Situation Report, 155. 20202020"},{"key":"B4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B6","unstructured":"Immunization Coverage2019"},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaci.2018.05.007","article-title":"Vaccination-induced herd immunity: successes and challenges","volume":"142","author":"Mallory","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2013.09.015","article-title":"Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain)","volume":"18","author":"Plans","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/j.jinf.2020.03.027","article-title":"Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries","volume":"80","author":"Kwok","year":"2020","journal-title":"J Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","article-title":"Human coronavirus: host-pathogen interaction","volume":"73","author":"Fung","year":"2019","journal-title":"Annu Rev Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-020-09137-5","article-title":"COVID 19: a clue from innate immunity","volume":"10","author":"Birra","year":"2020","journal-title":"Immunol Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses."},{"key":"B19","unstructured":"DRAFT Landscape of COVID-19 Candidate Vaccines2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.3390\/vaccines8020153","article-title":"Progress and prospects on vaccine development against SARS-CoV-2","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"E220","DOI":"10.3390\/vaccines8020220","article-title":"A novel synonymous mutation of SARS-CoV-2: is this possible to affect their antigenicity and immunogenicity?","volume":"8","author":"Kim","year":"2020","journal-title":"Vaccines."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cub.2020.03.022","article-title":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(20)30673-5","article-title":"COVID-19: towards controlling of a pandemic","volume":"395","author":"Bedford","year":"2020","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.21203\/rs.3.rs-16836\/v1","article-title":"Respiratory virus shedding in exhaled breath and efficacy of face masks","volume":"26","author":"Leung","year":"2020","journal-title":"Nat Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S2468-1253(20)30083-2","article-title":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples","volume":"5","author":"Wu","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"10","author":"Lauer","year":"2020","journal-title":"Ann Intern Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","author":"Lagunas-Rangel","year":"2020","journal-title":"J Med Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"104811","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antiviral Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","article-title":"Dysregulation of type I interferon responses in COVID-19","volume":"20","author":"Acharya","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11357-020-00186-0","article-title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes","volume":"42","author":"Nikolich-Zugich","year":"2020","journal-title":"Geroscience."},{"key":"B43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni.1979","article-title":"Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5","volume":"12","author":"Zust","year":"2011","journal-title":"Nat Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e30802","DOI":"10.1371\/journal.pone.0030802","article-title":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.it.2020.04.008","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"14","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1038\/emi.2012.26","article-title":"Understanding the T cell immune response in SARS coronavirus infection","volume":"1","author":"Janice Oh","year":"2012","journal-title":"Emerg Microbes Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa462","article-title":"Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients","author":"Ouyang","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biol Mood Anxiety Disord."},{"key":"B54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.coviro.2013.01.001","article-title":"Animal models for highly pathogenic emerging viruses","volume":"3","author":"Safronetz","year":"2013","journal-title":"Curr Opin Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J Virol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","author":"Bao","year":"2020","journal-title":"Nature."},{"key":"B57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/nm.2972","article-title":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","volume":"18","author":"Graham","year":"2012","journal-title":"Nat Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","article-title":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tim.2006.05.007","article-title":"Is there an ideal animal model for SARS?","volume":"14","author":"Subbarao","year":"2006","journal-title":"Trends Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1128\/JVI.79.9.5833-5838.2005","article-title":"Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virusres.2007.03.025","article-title":"Animal models and vaccines for SARS-CoV infection","volume":"133","author":"Roberts","year":"2008","journal-title":"Virus Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","article-title":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice","volume":"173","author":"Glass","year":"2004","journal-title":"J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1126\/science.1240532","article-title":"H7N9 influenza viruses are transmissible in ferrets by respiratory droplet","volume":"341","author":"Zhang","year":"2013","journal-title":"Science."},{"key":"B67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature."},{"key":"B68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.virol.2007.12.032","article-title":"The SARS-CoV ferret model in an infection-challenge study","volume":"374","author":"Chu","year":"2008","journal-title":"Virology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi","year":"2020","journal-title":"Science."},{"key":"B70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e69127","DOI":"10.1371\/journal.pone.0069127","article-title":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters","volume":"8","author":"de Wit","year":"2013","journal-title":"PLoS ONE."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility","author":"Chan","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/2020.03.17.995639","article-title":"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model","volume":"368","author":"Rockx","year":"2020","journal-title":"Science."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-0316-3","article-title":"Will we see protection or reinfection in COVID-19?","volume":"17","author":"Ota","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ame2.12108","article-title":"Age-related rhesus macaque models of COVID-19","volume":"3","author":"Yu","year":"2020","journal-title":"Animal Model Exp Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aab3886","article-title":"Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1084\/jem.20182160","article-title":"Vaccines: an achievement of civilization, a human right, our health insurance for the future","volume":"216","author":"Rappuoli","year":"2018","journal-title":"J Exp Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"7939","DOI":"10.1016\/j.vaccine.2010.09.076","article-title":"Development and evaluation of a formalin-inactivated West Nile virus vaccine (WN-VAX) for a human vaccine candidate","volume":"28","author":"Posadas-Herrera","year":"2010","journal-title":"Vaccine."},{"key":"B80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12985-015-0282-8","article-title":"The efficacy of inactivated west Nile vaccine (WN-VAX) in mice and monkeys","volume":"12","author":"Muraki","year":"2015","journal-title":"Virol J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1537-2995.2012.03717.x","article-title":"Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system","volume":"53","author":"Vanlandingham","year":"2013","journal-title":"Transfusion."},{"key":"B82","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/trf.12899","article-title":"The effect of riboflavin and ultraviolet light on the infectivity of arboviruses","volume":"55","author":"Faddy","year":"2015","journal-title":"Transfusion."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1111\/trf.13860","article-title":"Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment","volume":"56","author":"Keil","year":"2016","journal-title":"Transfusion."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.vaccine.2018.03.067","article-title":"Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults","volume":"36","author":"Hyer","year":"2018","journal-title":"Vaccine."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1016\/j.vaccine.2019.08.005","article-title":"Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg\/CpG 1018, in persons with diabetes mellitus aged 60-70years","volume":"37","author":"Hyer","year":"2019","journal-title":"Vaccine."},{"key":"B86","doi-asserted-by":"publisher","first-page":"eabc1932","DOI":"10.1126\/science.abc1932","article-title":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2","volume":"6","author":"Gao","year":"2020","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e0223784","DOI":"10.1371\/journal.pone.0223784","article-title":"Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets","volume":"14","author":"Stauft","year":"2019","journal-title":"PLoS ONE."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1016\/j.vaccine.2020.02.056","article-title":"A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates","volume":"38","author":"Mueller","year":"2020","journal-title":"Vaccine."},{"key":"B89","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform","volume":"89","author":"Malczyk","year":"2015","journal-title":"J Virol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e01485","DOI":"10.1128\/JVI.01485-18","article-title":"A measles virus-based vaccine candidate mediates protection against zika virus in an allogeneic mouse pregnancy model","volume":"93","author":"Nurnberger","year":"2019","journal-title":"J Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1016\/j.vaccine.2016.07.051","article-title":"Immunogenicity of next-generation HPV vaccines in non-human primates: measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine","volume":"34","author":"Gupta","year":"2016","journal-title":"Vaccine."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/10_2018_61","article-title":"Glycobiotechnology of the insect cell-baculovirus expression system technology","author":"Palomares","year":"2018","journal-title":"Adv Biochem Eng Biotechnol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/infdis\/jix478","article-title":"Randomized comparison of immunogenicity and safety of quadrivalent recombinant versus inactivated influenza vaccine in healthy adults 18-49 years of age","volume":"216","author":"Dunkle","year":"2017","journal-title":"J Infect Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.vaccine.2017.02.057","article-title":"Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: a phase II, observer-blind, randomized, controlled trial","volume":"35","author":"Madan","year":"2017","journal-title":"Vaccine."},{"key":"B95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2019.10.042","article-title":"Formulation design, optimization and in vivo evaluations of an alpha-tocopherol-containing self-emulsified adjuvant system using inactivated influenza vaccine","volume":"316","author":"Lodaya","year":"2019","journal-title":"J Control Release."},{"key":"B96","doi-asserted-by":"publisher","first-page":"eaax7888","DOI":"10.1126\/scitranslmed.aax7888","article-title":"A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus","volume":"11","author":"Hobson-Peters","year":"2019","journal-title":"Sci Transl Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1080\/21645515.2019.1625644","article-title":"A ten-year study of immunogenicity and safety of the AS04-HPV-16\/18 vaccine in adolescent girls aged 10-14 years","volume":"15","author":"Schwarz","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jnci\/djz074","article-title":"Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial","volume":"112","author":"Qiao","year":"2020","journal-title":"J Natl Cancer Inst."},{"key":"B99","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"N Engl J Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/v11030212","article-title":"Efficacy of an adjuvanted Middle East respiratory syndrome coronavirus spike protein vaccine in dromedary camels and alpacas","volume":"11","author":"Adney","year":"2019","journal-title":"Viruses."},{"key":"B102","first-page":"19","article-title":"Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company","volume":"96","author":"Moise","year":"2013","journal-title":"R I Med J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/17460441.2011.534454","article-title":"Harnessing the power of genomics and immunoinformatics to produce improved vaccines","volume":"6","author":"Moise","year":"2011","journal-title":"Expert Opin Drug Discov."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1080\/21645515.2015.1061159","article-title":"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines","volume":"11","author":"Moise","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4049\/jimmunol.1900379","article-title":"A computationally optimized broadly reactive antigen subtype-specific influenza vaccine strategy elicits unique potent broadly neutralizing antibodies against hemagglutinin","volume":"204","author":"Sautto","year":"2020","journal-title":"J Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fimmu.2018.00205","article-title":"Pathogenicity and viral shedding of MERS-CoV in immunocompromised rhesus macaques","volume":"9","author":"Prescott","year":"2018","journal-title":"Front Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/jmv.21824","article-title":"Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus","volume":"82","author":"Ichinohe","year":"2010","journal-title":"J Med Virol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1016\/j.micinf.2006.07.018","article-title":"Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection","volume":"8","author":"Asahi-Ozaki","year":"2006","journal-title":"Microbes Infect."},{"key":"B110","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.ebiom.2020.102743","article-title":"Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development","volume":"55","author":"Kim","year":"2020","journal-title":"EBioMedicine."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4049\/jimmunol.1202655","article-title":"Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus","volume":"190","author":"Strbo","year":"2013","journal-title":"J Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12026-013-8468-x","article-title":"Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases","volume":"57","author":"Strbo","year":"2013","journal-title":"Immunol Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.xphs.2017.04.037","article-title":"Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate","volume":"106","author":"Chen","year":"2017","journal-title":"J Pharm Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/infdis\/jiy177","article-title":"A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults: a first-in-humans study","volume":"218","author":"Langley","year":"2018","journal-title":"J Infect Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41541-019-0102-z","article-title":"Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal bacillus anthracis spore inhalation challenge","volume":"4","author":"Weir","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B117","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1016\/j.vaccine.2011.04.103","article-title":"ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors","volume":"29","author":"Kovjazin","year":"2011","journal-title":"Vaccine."},{"key":"B118","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bjh.13245","article-title":"Phase I\/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients","volume":"169","author":"Carmon","year":"2015","journal-title":"Br J Haematol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fimmu.2017.00640","article-title":"An approach for a synthetic CTL vaccine design against zika flavivirus using class I and class II epitopes identified by computer modeling","volume":"8","author":"Cunha-Neto","year":"2017","journal-title":"Front Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1016\/j.vaccine.2014.05.071","article-title":"Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL\/6 mouse model using peptide-containing biodegradable microspheres and adjuvants","volume":"32","author":"Rubsamen","year":"2014","journal-title":"Vaccine."},{"key":"B121","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.vaccine.2009.05.054","article-title":"Ii-Key\/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers","volume":"27","author":"Xu","year":"2009","journal-title":"Vaccine."},{"key":"B122","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-10-0085","article-title":"Results from a phase I clinical study of the novel Ii-Key\/HER-2\/neu(776-790) hybrid peptide vaccine in patients with prostate cancer","volume":"16","author":"Perez","year":"2010","journal-title":"Clin Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1016\/j.vaccine.2017.05.067","article-title":"A novel combination adjuvant platform for human and animal vaccines","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine."},{"key":"B124","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1016\/j.vaccine.2011.07.009","article-title":"Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis","volume":"29","author":"Garlapati","year":"2011","journal-title":"Vaccine."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e0141713","DOI":"10.1371\/journal.pone.0141713","article-title":"Mucosal immunogenicity of genetically modified lactobacillus acidophilus expressing an HIV-1 epitope within the surface layer protein","volume":"10","author":"Kajikawa","year":"2015","journal-title":"PLoS ONE."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e0196950","DOI":"10.1371\/journal.pone.0196950","article-title":"Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant lactobacillus vaccine platform","volume":"13","author":"Bumgardner","year":"2018","journal-title":"PLoS ONE."},{"key":"B127","doi-asserted-by":"publisher","first-page":"30357","DOI":"10.1038\/srep30357","article-title":"Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a drosophila melanogaster Schneider 2 stable cell line system","volume":"6","author":"Hjerrild","year":"2016","journal-title":"Sci Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","article-title":"First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria","volume":"69","author":"Mordmuller","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-019-1250-z","article-title":"Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques","volume":"570","author":"Escolano","year":"2019","journal-title":"Nature."},{"key":"B130","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1038\/s41598-019-41522-5","article-title":"A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine","volume":"9","author":"Janitzek","year":"2019","journal-title":"Sci Rep."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/bit.27273","article-title":"Plant-derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells","volume":"117","author":"Schwestka","year":"2020","journal-title":"Biotechnol Bioeng."},{"key":"B132","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/pbi.12986","article-title":"Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever","volume":"17","author":"Laughlin","year":"2019","journal-title":"Plant Biotechnol J."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia Ankara-vectored Ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA."},{"key":"B134","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/pathogens8030133","article-title":"A single dose of modified vaccinia Ankara expressing Lassa virus-like particles protects mice from lethal intra-cerebral virus challenge","volume":"8","author":"Salvato","year":"2019","journal-title":"Pathogens."},{"key":"B135","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41598-017-19041-y","article-title":"A single dose of modified vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge","volume":"8","author":"Domi","year":"2018","journal-title":"Sci Rep."},{"key":"B136","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J Virol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science."},{"key":"B138","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.clim.2014.08.003","article-title":"Influenza virus-like particle vaccines made in nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens","volume":"154","author":"Landry","year":"2014","journal-title":"Clin Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"e0216533","DOI":"10.1371\/journal.pone.0216533","article-title":"Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-two randomized Phase II clinical trials in 18 to 49 and >\/=50 years old adults","volume":"14","author":"Pillet","year":"2019","journal-title":"PLoS ONE."},{"key":"B140","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1128\/CVI.00552-12","article-title":"An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models","volume":"20","author":"Scallan","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(19)30584-5","article-title":"Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study","volume":"20","author":"Liebowitz","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"eaaw2853","DOI":"10.1126\/sciadv.aaw2853","article-title":"Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display","volume":"5","author":"Vragniau","year":"2019","journal-title":"Sci Adv."},{"key":"B143","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jinf.2019.02.003","article-title":"Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults","volume":"78","author":"Green","year":"2019","journal-title":"J Infect."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e00554","DOI":"10.1128\/mBio.00554-20","article-title":"Single-dose, intranasal immunization with recombinant parainfluenza virus 5 expressing Middle East respiratory syndrome coronavirus (MERS-CoV) spike protein protects mice from fatal MERS-CoV infection","volume":"11","author":"Li","year":"2020","journal-title":"mBio."},{"key":"B146","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","article-title":"Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial","volume":"15","author":"Ramsauer","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.virol.2014.01.002","article-title":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein","author":"Escriou","year":"2014","journal-title":"Virology."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e0188453","DOI":"10.1371\/journal.pone.0188453","article-title":"Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments","volume":"13","author":"Noyce","year":"2018","journal-title":"PLoS ONE."},{"key":"B149","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1128\/JVI.00945-06","article-title":"Genome of horsepox virus","volume":"80","author":"Tulman","year":"2006","journal-title":"J Virol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1128\/JVI.03441-13","article-title":"Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates","volume":"88","author":"Clarke","year":"2014","journal-title":"J Virol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e02180","DOI":"10.1128\/mBio.02180-19","article-title":"Generation of DelNS1 influenza viruses: a strategy for optimizing live attenuated influenza vaccines","volume":"10","author":"Wang","year":"2019","journal-title":"mBio."},{"key":"B153","doi-asserted-by":"publisher","first-page":"10273","DOI":"10.1128\/JVI.00919-15","article-title":"An A14U substitution in the 3' noncoding region of the M segment of viral RNA supports replication of influenza virus with an NS1 deletion by modulating alternative splicing of M segment mRNAs","volume":"89","author":"Zheng","year":"2015","journal-title":"J Virol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1016\/j.vaccine.2017.06.039","article-title":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","volume":"35","author":"Hatta","year":"2017","journal-title":"Vaccine."},{"key":"B155","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1016\/j.vaccine.2018.06.053","article-title":"Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity","volume":"36","author":"Hatta","year":"2018","journal-title":"Vaccine."},{"key":"B156","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/hum.2013.103","article-title":"Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2\/neu in preclinical models","volume":"25","author":"Aurisicchio","year":"2014","journal-title":"Hum Gene Ther."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e27529","DOI":"10.4161\/onci.27529","article-title":"A novel minigene scaffold for therapeutic cancer vaccines","volume":"3","author":"Aurisicchio","year":"2014","journal-title":"Oncoimmunology."},{"key":"B158","first-page":"140","article-title":"Transfection of human HGF plasmid DNA improves limb salvage in buerger's disease patients with critical limb ischemia","volume":"30","author":"Shigematsu","year":"2011","journal-title":"Int Angiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.114.04534","article-title":"Long-term reduction of high blood pressure by angiotensin II DNA vaccine in spontaneously hypertensive rats","volume":"66","author":"Koriyama","year":"2015","journal-title":"Hypertension."},{"key":"B160","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.micpath.2009.01.001","article-title":"Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration","volume":"46","author":"Leckenby","year":"2009","journal-title":"Microb Pathog."},{"key":"B161","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1016\/j.vaccine.2010.09.001","article-title":"Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a salmonella enterica vector","volume":"28","author":"Huang","year":"2010","journal-title":"Vaccine."},{"key":"B162","doi-asserted-by":"publisher","first-page":"4857869","DOI":"10.1155\/2016\/4857869","article-title":"CryJ-LAMP DNA vaccines for Japanese red cedar allergy induce robust Th1-type immune responses in murine model","volume":"2016","author":"Su","year":"2016","journal-title":"J Immunol Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1016\/j.vaccine.2015.06.071","article-title":"Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine."},{"key":"B164","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2018.03.030","article-title":"Immunogenicity and antitumor activity of the superlytic lambdaF7 phage nanoparticles displaying a HER2\/neu-derived peptide AE37 in a tumor model of BALB\/c mice","volume":"424","author":"Barati","year":"2018","journal-title":"Cancer Lett."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41598-018-38371-z","article-title":"Lambda bacteriophage nanoparticles displaying GP2, a HER2\/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice","volume":"9","author":"Razazan","year":"2019","journal-title":"Sci Rep."},{"key":"B166","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1021\/acs.biomac.8b00429","article-title":"One size does not fit all: the effect of chain length and charge density of poly(ethylene imine) based copolymers on delivery of pDNA, mRNA, and RepRNA polyplexes","volume":"19","author":"Blakney","year":"2018","journal-title":"Biomacromolecules."},{"key":"B168","doi-asserted-by":"publisher","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1158\/0008-5472.CAN-11-2957","article-title":"Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy","volume":"72","author":"Van Lint","year":"2012","journal-title":"Cancer Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/annonc\/mdt245","article-title":"A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients","volume":"24","author":"Wilgenhof","year":"2013","journal-title":"Ann Oncol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","article-title":"mRNA delivery for therapeutic anti-HER2 antibody expression in vivo","volume":"27","author":"Rybakova","year":"2019","journal-title":"Mol Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"17385","DOI":"10.1038\/s41598-018-35724-6","article-title":"A vaccine based on a modified vaccinia virus Ankara vector expressing zika virus structural proteins controls zika virus replication in mice","volume":"8","author":"Perez","year":"2018","journal-title":"Sci Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"e00363","DOI":"10.1128\/JVI.00363-18","article-title":"Distinct immunogenicity and efficacy of poxvirus-based vaccine candidates against Ebola virus expressing GP and VP40 proteins","volume":"92","author":"Lazaro-Frias","year":"2018","journal-title":"J Virol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.aaa4919","article-title":"Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates","volume":"348","author":"Marzi","year":"2015","journal-title":"Science."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/21645515.2015.1123357","article-title":"Safety, immunogenicity and cross-reactivity of a Northern hemisphere 2013-2014 seasonal trivalent inactivated split influenza virus vaccine, Anflu(R)","volume":"12","author":"Shen","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B177","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1473-3099(20)30235-8","article-title":"SARS-CoV-2: virus dynamics and host response","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B179","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jmii.2020.03.021","article-title":"Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019","volume":"53","author":"Xing","year":"2020","journal-title":"J Microbiol Immunol Infect."},{"key":"B180","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.micinf.2014.12.006","article-title":"Advancements in the development of subunit influenza vaccines","volume":"17","author":"Zhang","year":"2015","journal-title":"Microbes Infect."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun."},{"key":"B182","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1038\/s41598-017-09518-1","article-title":"Improvement of pharmacokinetic profile of TRAIL via Trimer-Tag enhances its antitumor activity in vivo","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep."},{"key":"B183","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1038\/s41598-018-25652-w","article-title":"Trivalent soluble TNF receptor, a potent TNF-alpha antagonist for the treatment collagen-induced arthritis","volume":"8","author":"Cui","year":"2018","journal-title":"Sci Rep."},{"key":"B184","volume-title":"Inventors Chimeric Molecules and Uses Thereof.","author":"Chappell","year":"2018"},{"key":"B185","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2018.07.021","article-title":"A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3","volume":"158","author":"Garg","year":"2018","journal-title":"Antiviral Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1016\/j.vaccine.2014.09.030","article-title":"An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization","volume":"32","author":"Raghunandan","year":"2014","journal-title":"Vaccine."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.vaccine.2013.01.039","article-title":"Immune enhancing properties of the novel Matrix-M adjuvant leads to potentiated immune responses to an influenza vaccine in mice","volume":"31","author":"Magnusson","year":"2013","journal-title":"Vaccine."},{"key":"B188","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-60761-533-0_11","article-title":"Lentiviral vector transduction of dendritic cells for novel vaccine strategies","volume":"614","author":"Chang","year":"2010","journal-title":"Methods Mol Biol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.vaccine.2006.02.025","article-title":"An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine."},{"key":"B190","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-59745-561-9_13","article-title":"Immunity of lentiviral vector-modified dendritic cells","volume":"542","author":"Han","year":"2009","journal-title":"Methods Mol Biol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine."},{"key":"B192","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet."},{"key":"B193","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"B194","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1128\/JVI.77.1.799-803.2003","article-title":"Overcoming immunity to a viral vaccine by DNA priming before vector boosting","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e33428","DOI":"10.1371\/journal.pone.0033428","article-title":"Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine","volume":"7","author":"Pandey","year":"2012","journal-title":"PLoS ONE."},{"key":"B196","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biotechadv.2012.10.001","article-title":"Development of hybrid viral vectors for gene therapy","volume":"31","author":"Huang","year":"2013","journal-title":"Biotechnol Adv."},{"key":"B197","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature."},{"key":"B198","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1073\/pnas.0806901105","article-title":"A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","article-title":"Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice","volume":"166","author":"Escolano","year":"2016","journal-title":"Cell."},{"key":"B200","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40425-018-0423-x","article-title":"7-11 November 2018","volume":"6","year":"2018","journal-title":"J Immunother Cancer."},{"key":"B201","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/vaccines8010056","article-title":"Immune therapy targeting E6\/E7 oncogenes of human paillomavirus type 6 (HPV-6) reduces or eliminates the need for surgical intervention in the treatment of HPV-6 associated recurrent respiratory papillomatosis","volume":"8","author":"Aggarwal","year":"2020","journal-title":"Vaccines."},{"key":"B202","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.4161\/hv.24702","article-title":"Tolerability of intramuscular and intradermal delivery by CELLECTRA((R)) adaptive constant current electroporation device in healthy volunteers","volume":"9","author":"Diehl","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B203","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijrobp.2020.02.031","article-title":"A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6\/E7 oncogenes after chemoradiation for cervical cancer","volume":"107","author":"Hasan","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell."},{"key":"B205","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41541-020-0163-z","article-title":"Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection","volume":"5","author":"Espeseth","year":"2020","journal-title":"NPJ Vaccines."},{"key":"B206","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"key":"B207","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm.4356","article-title":"Elimination of large tumors in mice by mRNA-encoded bispecific antibodies","volume":"23","author":"Stadler","year":"2017","journal-title":"Nat Med."},{"key":"B208","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ymthe.2019.09.009","article-title":"A Trans-amplifying RNA vaccine strategy for induction of potent protective immunity","volume":"28","author":"Beissert","year":"2020","journal-title":"Mol Ther."},{"key":"B209","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2013developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"B212","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:56:59Z","timestamp":1667494619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":213,"alternative-id":["10.3389\/fimmu.2020.01817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"article-number":"1817"}}